176 related articles for article (PubMed ID: 20828853)
1. Rosiglitazone promotes fatty acyl CoA accumulation and excessive glycogen storage in livers of mice without adiponectin.
Zhou M; Xu A; Lam KS; Tam PK; Che CM; Chan L; Lee IK; Wu D; Wang Y
J Hepatol; 2010 Dec; 53(6):1108-16. PubMed ID: 20828853
[TBL] [Abstract][Full Text] [Related]
2. Involvement of adiponectin-SIRT1-AMPK signaling in the protective action of rosiglitazone against alcoholic fatty liver in mice.
Shen Z; Liang X; Rogers CQ; Rideout D; You M
Am J Physiol Gastrointest Liver Physiol; 2010 Mar; 298(3):G364-74. PubMed ID: 20007851
[TBL] [Abstract][Full Text] [Related]
3. Hepatoprotective Effects of Soybean Embryo by Enhancing Adiponectin-Mediated AMP-Activated Protein Kinase α Pathway in High-Fat and High-Cholesterol Diet-Induced Nonalcoholic Fatty Liver Disease.
Hong J; Kim S; Kim HS
J Med Food; 2016 Jun; 19(6):549-59. PubMed ID: 27266339
[TBL] [Abstract][Full Text] [Related]
4. Rosiglitazone Elicits an Adiponectin-Mediated Insulin-Sensitizing Action at the Adipose Tissue-Liver Axis in Otsuka Long-Evans Tokushima Fatty Rats.
Li J; Xue YM; Zhu B; Pan YH; Zhang Y; Wang C; Li Y
J Diabetes Res; 2018; 2018():4627842. PubMed ID: 30225267
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial dysfunction contributes to the increased vulnerabilities of adiponectin knockout mice to liver injury.
Zhou M; Xu A; Tam PK; Lam KS; Chan L; Hoo RL; Liu J; Chow KH; Wang Y
Hepatology; 2008 Oct; 48(4):1087-96. PubMed ID: 18698578
[TBL] [Abstract][Full Text] [Related]
6. Effects of dietary genistein on hepatic lipid metabolism and mitochondrial function in mice fed high-fat diets.
Lee YM; Choi JS; Kim MH; Jung MH; Lee YS; Song J
Nutrition; 2006 Sep; 22(9):956-64. PubMed ID: 16814985
[TBL] [Abstract][Full Text] [Related]
7. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
Liu LF; Purushotham A; Wendel AA; Belury MA
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
[TBL] [Abstract][Full Text] [Related]
8. Fucosylated chondroitin sulfate from sea cucumber in combination with rosiglitazone improved glucose metabolism in the liver of the insulin-resistant mice.
Hu S; Chang Y; Wang J; Xue C; Li Z; Wang Y
Biosci Biotechnol Biochem; 2013; 77(11):2263-8. PubMed ID: 24200792
[TBL] [Abstract][Full Text] [Related]
9. Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins.
González-Périz A; Horrillo R; Ferré N; Gronert K; Dong B; Morán-Salvador E; Titos E; Martínez-Clemente M; López-Parra M; Arroyo V; Clària J
FASEB J; 2009 Jun; 23(6):1946-57. PubMed ID: 19211925
[TBL] [Abstract][Full Text] [Related]
10. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
11. Dietary camphene attenuates hepatic steatosis and insulin resistance in mice.
Kim S; Choi Y; Choi S; Choi Y; Park T
Obesity (Silver Spring); 2014 Feb; 22(2):408-17. PubMed ID: 23818423
[TBL] [Abstract][Full Text] [Related]
12. [Expression of uncoupling protein 2 and its relationship to the content of adenosine triphosphate in the nonalcoholic fatty livers of rats fed a high-fat diet].
Fan JG; Ding XD; Wang GL; Xu ZJ; Tian LY; Zheng XY
Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):374-7. PubMed ID: 15918975
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiling in livers of mice after acute inhibition of beta-oxidation.
van der Leij FR; Bloks VW; Grefhorst A; Hoekstra J; Gerding A; Kooi K; Gerbens F; te Meerman G; Kuipers F
Genomics; 2007 Dec; 90(6):680-9. PubMed ID: 17933490
[TBL] [Abstract][Full Text] [Related]
14. Obesity-related fatty liver is unchanged in mice deficient for mitochondrial uncoupling protein 2.
Baffy G; Zhang CY; Glickman JN; Lowell BB
Hepatology; 2002 Apr; 35(4):753-61. PubMed ID: 11915020
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial uncoupling protein-2 mediates steatotic liver injury following ischemia/reperfusion.
Evans ZP; Ellett JD; Schmidt MG; Schnellmann RG; Chavin KD
J Biol Chem; 2008 Mar; 283(13):8573-9. PubMed ID: 18086675
[TBL] [Abstract][Full Text] [Related]
16. Liver adapts mitochondrial function to insulin resistant and diabetic states in mice.
Franko A; von Kleist-Retzow JC; Neschen S; Wu M; Schommers P; Böse M; Kunze A; Hartmann U; Sanchez-Lasheras C; Stoehr O; Huntgeburth M; Brodesser S; Irmler M; Beckers J; de Angelis MH; Paulsson M; Schubert M; Wiesner RJ
J Hepatol; 2014 Apr; 60(4):816-23. PubMed ID: 24291365
[TBL] [Abstract][Full Text] [Related]
17. Uncoupling protein-2 (UCP2) induces mitochondrial proton leak and increases susceptibility of non-alcoholic steatohepatitis (NASH) liver to ischaemia-reperfusion injury.
Serviddio G; Bellanti F; Tamborra R; Rollo T; Capitanio N; Romano AD; Sastre J; Vendemiale G; Altomare E
Gut; 2008 Jul; 57(7):957-65. PubMed ID: 18308829
[TBL] [Abstract][Full Text] [Related]
18. Acyl-Coenzyme A Thioesterase 9 Traffics Mitochondrial Short-Chain Fatty Acids Toward De Novo Lipogenesis and Glucose Production in the Liver.
Steensels S; Qiao J; Zhang Y; Maner-Smith KM; Kika N; Holman CD; Corey KE; Bracken WC; Ortlund EA; Ersoy BA
Hepatology; 2020 Sep; 72(3):857-872. PubMed ID: 32498134
[TBL] [Abstract][Full Text] [Related]
19. Blockade of interleukin 6 signalling ameliorates systemic insulin resistance through upregulation of glucose uptake in skeletal muscle and improves hepatic steatosis in high-fat diet fed mice.
Yamaguchi K; Nishimura T; Ishiba H; Seko Y; Okajima A; Fujii H; Tochiki N; Umemura A; Moriguchi M; Sumida Y; Mitsuyoshi H; Yasui K; Minami M; Okanoue T; Itoh Y
Liver Int; 2015 Feb; 35(2):550-61. PubMed ID: 25066281
[TBL] [Abstract][Full Text] [Related]
20. Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis.
Svegliati-Baroni G; Saccomanno S; Rychlicki C; Agostinelli L; De Minicis S; Candelaresi C; Faraci G; Pacetti D; Vivarelli M; Nicolini D; Garelli P; Casini A; Manco M; Mingrone G; Risaliti A; Frega GN; Benedetti A; Gastaldelli A
Liver Int; 2011 Oct; 31(9):1285-97. PubMed ID: 21745271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
